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Available online xxxxThis paper offers a newway of understanding the course of a chronic, neurological condition through a compre-
hensive model of patient-reported determinants of health and wellbeing: The Patient Reported ImpleMentation
sciEnce (PRIME) model is the ﬁrst model of its kind to be based on patient-driven insights for the design and im-
plementation of initiatives that could improve tertiary, primary, and community healthcare services for patients
with refractory epilepsy, and has broad implications for other disorders; PRIME focuses on: patient-reported de-
terminants of health and wellbeing, pathways through care, gaps in treatment and other system delays, patient
need and expectation, and barriers and facilitators to high-quality care provision; PRIME highlights that in the
context of refractory epilepsy, patients value appropriate, clear, and speedy referrals from primary care practi-
tioners and community neurologists to specialist healthcare professionals based in tertiary epilepsy centers.
Many patients also want to share in decisions around treatment and care, and gain a greater understanding of
their debilitating disease, so as to ﬁnd ways to self-manage their illness more effectively and plan for the future.
Here, PRIME is presented using refractory epilepsy as the exemplar case, while the model remains ﬂexible,
suitable for adaptation to other settings, patient populations, and conditions; PRIME comprises six critical levels:
1) The Individual PatientModel; 2) The Patient RelationshipsModel; 3) The Patient Care PathwaysModel; 4) The
Patient Transitions Model; 5) The Pre- and Postintervention Model; and 6) The Comprehensive Patient Model.
Each level is dealt with in detail, while Levels 5 and 6 are presented in terms of where the gaps lie in our current
knowledge, in particular in relation to patients' journeys through healthcare, system intersections, and individ-
uals adaptive behavior following resective surgery, as well as others' views of the disease, such as family
members.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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1.1. Implementation science for translating evidence into policy and
practice
A clear gap has been identiﬁed, across a number of medical ﬁelds,
between research study outputs and the implementation of scientiﬁ-
cally proven health interventions, described as an “ongoing barrierInnovation, Level 6, Room638,
t).
. This is an open access article underbetween concept to clinic” [1]. The gap can most usefully be addressed
with the application of models of care underpinned by implementation
science; the study of strategies to promote intervention uptake that
prove effective in routine practice [2].
In the health service and medical research ﬁelds, implementation
science advocates effective, evidence-based interventions, in targeted
settings, to improve health and wellbeing for speciﬁc populations [3].
Implementation science seeks to examine a wide range of intervention
effects, and the long-term sustainability of new knowledge as it is
integrated into clinical practice [4]. As a result, implementation science
concentrates on not only evidence translation, but also uptake,
acquisition, and dissemination (ﬁdelity, spread, and assessment) [5].
By throwing its net widely, implementation science can strengthenthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Illustration 1. Foundational implementation science concepts underlying the development
of PRIME.
Source: Rapport et al. [9] based on Rabin et al. [14]
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patients, and the systems in which they work [4,6,7].
1.2. Implementation science in neurological and brain disorder ﬁelds
For implementation science to be effective, however, across medical
ﬁelds includingneurology andbrain disorders, a carefully crafted imple-
mentationmodel is needed. Thismakes the disease condition accessible
to others, can act as a communication device and framework for change,
and inform new interventions to bring evidence into practice [8].
Implementation models (also known as ‘frameworks’ or ‘theories’
[9]) aim to inﬂuence both process and procedure and successfully trans-
late research outcomes into practical solutions for healthcare delivery.
They must be contextually relevant and capable of problem resolution
[10]. However, selecting an appropriate model is not easy. Choices
must be relevant to the scientiﬁc or social scientiﬁc context [4,11], and
effective in addressing a host of complex factors such as how to relate
long-term care planning to priority-setting, and shared-care [12].
They must be topic-sensitive [9,13], open to reﬁnement, and include
achievable goals [14].
However, to choose a model that will be effective, researchers face a
host of complex challenges. They have to weigh up the strengths and
weaknesses of different variables, identify their methodological
strengths and weaknesses, and decide whether to use a model already
in existence or design something new. A multidisciplinary team of
scientists and social scientists, methodologists, and healthcare profes-
sionals can help with this, examining disease ‘ﬁt’, sifting through less
or more relevant variables, and factoring in key knowledge translation
matters.
1.3. Scientiﬁc models already in existence in the neurology and brain
disorder ﬁeld
Wensing et al. [15] have designed a model for chronic conditions to
examine the determinants of practice. Their model concentrates on
healthcare professional-reported practice, and uses clinically-focused
interviews and expert professional groups to assess the impact of pro-
fessional reporting on clinical care. Theirmodel is generic and applicable
across chronic conditions. Within the neurology and brain disorder
ﬁelds there are also bioscientiﬁc models in use. These include models
that indicate disease phenotypes through advanced neuroimaging
[16]; microsimulations of brain disorders [17]; loss of visual acuity in
Multiple Sclerosis [18]; drug discovery in Alzheimer's, Huntington,
and Parkinson's Disease [19]; and cognitive ﬂexibility in the Autism
Spectrum Disorder [20]. There has also been a Toolkit to improve
professional practice in brain research in middle- and low-income
countries https://www.ﬁc.nih.gov/About/center-global-health-studies/
neuroscience-implementation-toolkit, Quality-of-Life (QoL) proﬁling
for patients with active epilepsy [21], diagrammatic impressions of
resilience in the context of epilepsy [22], and illustrations of patient nar-
ratives of journeys to surgery [23]. However,Wensing et al.'smodel [15]
concentrates on clinician-driven data, while the QoL and patient
proﬁling work outlined above concentrates on speciﬁc, often singular
aspects of a patient's life (such as their degree of activity or extent of
physical movement). As a result, these latter models lack scope and
the former,Wensingmodel is not particularly relevant to the current in-
terest. For example, the Toolkit to improve professional practice con-
centrates on an educational package, and the bioscientiﬁc models
attend to clinical improvements, while emotional and psychosocial
wellbeing is rarely discussed — particularly not in its broader context.
Consequently, while focusing on the pathogenesis of a disease, extant
models overlook the implications of disease progression for patient ex-
perience. While considering how to manage drug tests, models to date
have downplayed patient responses to side effects, and while assessing
drug-taking, current models ignore the effect of a patient's personal
preferences and worries on concordance.This paper reports on the design of a newmodel, inwhichwe set out
to develop an entry point into understanding more about complex
chronic diseases, and in particular refractory epilepsy, from the patient
perspective. We also aimed to present a new pathway for patients to
surgery, as we recognized that moving between chronic epilepsy and
surgical intervention is confusing and daunting for patients.2. Methods/model presentation
2.1. Designing a model in chronic diseases
In order to develop ourmodel,we considered thework of Rabin et al.
[14] and our own writing on Implementation Science [9]. Rabin et al.
identiﬁed ﬁve foundational concepts underpinning implementation
science models. They are as follows: 1) Diffusion (models should have
the power to spread ideas and change behaviors), 2) Dissemination
(models should provide useful, clear evidence for targeted audiences),
3) Implementation (models should not only produce new knowledge
but provide harnessable solutions to improve service delivery),
4) Adoption (models should indicate processes and/or practices to
move knowledge forward in real-time settings), and 5) Sustainability
(models should lead to implementable interventions with long-term
scope). We applied these principles as we planned the development
of our model and questioned its clarity at both the individual and
group level. As the model took shape, we asked ourselves whether its
component parts were clearly aligned and coherent, rigorous, based
on the data collected; lent themselves to clinical evaluation and assess-
ment [24]; could create knowledge thatwould inform routine care [25];
ensured patient-reported outcome measures had the same leverage as
clinical measures; and could support revelations in theory and practice.
While all elements of Rabin's framework are important, their integra-
tive nature, translated into a model can 1) help to overcome system
variance, 2) lead to more sustainable intervention uptake, and 3) offer
greater opportunity for knowledge spread.The model that we describe was designed to encompass more than
just barriers and facilitators to evidence-based, high-quality care, as
others have done [26,27], in favor of a comprehensive assessment of
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wellbeing, 2) pathways through care, 3) gaps in treatment and other
system delays, and 4) patient needs and expectations. While others
have concentrated on applying models that are already in existence, in
order to advance the ﬁeld of knowledge translation and promote gener-
alizability [28], we see the value in the design of an entirely newmodel
that can contend speciﬁcally with patient-reporting in neurological and
brain conditions and that maps well to refractory epilepsy and surgery.
Thus, the model is of our own making. While we reﬂected on others'
writings on the topic, particularly the literature's extensive evidence-
base on foundational concepts in implementation science underpinning
model development [2–4], by creating a new model, we hoped to
expand on the scope of what current models can offer.
Using refractory epilepsy as the exemplar case, we recognized eight
primary conditions that were critical for this model, in line with our
previous work [9,29,30]. As follows, the model should:
1. Include clinical and nonclinical factors across the care continuum
2. Foreground patient views
3. Be robust, efﬁcacious and reliable in the face of system change
4. Examine multiperspectival aspects of patient care
5. Fit tertiary care contexts but be adaptable to community and primary
care context
6. Indicate new knowledge
7. Have relevance to a wide range of chronic conditions.
2.2. Levels of the model and working methods
The model — from hereon in also known as The Patient Reported,
ImpleMentation sciEnce (PRIME) model — can be represented across
six levels (Diagram 1).
In effect, PRIME, as an overarching vision and framework to explain
the delivery of care, contains six feed-in models. Diagram 1 illustrates
this, with the ﬁrst feed-in level being Level One, the Individual Patient
Model, working toward the ﬁnal feed-in level, Level Six, the Compre-
hensive Patient Model. As Diagram 1 indicates, as theModel progresses
toward Level Six the levels become increasingly more complex and less
complete, because of the gaps in our knowledge of Levels Four to Six.
The sections below show this while explaining each level in detail.
2.2.1. Level one: the individual patient model
The model's ﬁrst level, Level One, is The Individual Patient Model.
This reﬂects patients' real-time knowledge and individual “lived experi-
ences” [31].While patients' views and experiences guide all six levels, in
the exemplar case, they are derived from a research program thatDiagram 1. Six levtriangulated experiential knowledge, with an audit of patients' medical
records and epidemiological patient data [29]. The program (reported in
detail elsewhere [29]) comprised the following: 1) an assessment of
qualitative methods use in epilepsy research [19]; 2) epilepsy service
use (including patient mortality, drug use, and emergency department
admissions for 66,000 patients with epilepsy across NSW between
2011 and 2016) [32]; 3) patient and clinician characteristics for patients
accessing two Tertiary Epilepsy Centers (TECs) in NSW in 2017; 4) pa-
tient and clinician interviews and observations (conducted between
2017 and 2018) [30,33]; 5) patient-completed Health-Related Quality-
of-Life (HRQoL) surveys; and 6) an audit of medical records across
two TECs for 50 patients who were accessing services in 2014 [29] .
The funded program obtained all the necessary ethics and gover-
nance approvals from the lead university's Human Research Ethics
Committee (HREC), while Site Speciﬁc Approvals (SSAs) were obtained
from two hospital sites involved. The program followed the ethical prin-
ciples of the lead university and hospital sites, while fully informed con-
sent was obtained from patients and healthcare professionals before
any datawere collected. Following collection, all datawere anonymized,
remained conﬁdential, and were deidentiﬁed. All participants agreed to
anonymized data being included in study reports, publications, and
other study outputs.
The patient and clinician characteristics data and interview and ob-
servation data, in particular, helped focus PRIME on patient-reported
determinants of health and wellbeing, pathways through care, gaps in
treatment and other system delays, patient needs and expectations,
and barriers and facilitators to high-quality care provision. Data were
analyzed across multiple events, while a random sample of 12 patients
(six from each of two TECs offering surgical intervention, and six of their
consulting neurologists, three from each TEC, total sample n=18), pro-
vided rich, in-depth narratives about personal, public, and professional
experiences (See Box 1 for patient and clinician characteristics). The
sample size (n = 18) was enough to reach data saturation, while
multiple interviews ensured full member checking against data
collected, triangulated with data from patient medical record reviews.
In this research, while interviews and observations were ongoing, in-
terview transcripts and observation notes were assessed systematically,
through a combination of thematic and schema analyses [30,34]. These
methods are reported in detail elsewhere [35], but in brief, involve
consensus-building through analytic groupwork, around both a thematic
framework and its key themes and categories. Thematic analysis was
supported by vignette development (succinct schemas) [34], one for
each patient, that outlined key aspects of each patient's case (Box 2).
The technique is rigorous and enables a veriﬁcation of datasets. Itmatches
ﬁndings to aims and objectives and validates working methods. Ongoingels of PRIME.
Box 1
Patient and clinician characteristics.
• Twelve patients referred to one of the two NSW TECs for
surgical assessment.
• Five females/seven males: mean age 38 yrs., age range 23–
67 yrs., SD 12.5 yrs.; mean age of first reported seizure
onset 19 yrs., age range 2-37 yrs., SD 9.7 yrs.
• Patients at different stages along the care pathway.
• Patients involved in ongoing observations and interviews +
HRQOL survey.
• Three of 12 were recently referred to a TEC for clinical
evaluation.
• Four of 12 were undergoing presurgical assessment, one of
whom was undertaking a video-EEG, and another of whom
was at the late stages of presurgical assessment leading up
to neurosurgical consultation.
• Four patients were interviewed postsurgery, with one of
those reporting continued seizures, and another preparing
for a second surgery.
• Nine were married or in a defacto relationship, four of whom
had children, and another was the sole carer of a wife with
a disability.
• Seven patients were unemployed, while the remaining
five were in either part-time (N = 2) or full-time (N = 3)
employment.
• Three clinicians from each study site were recruited. Two =
early-career, 2 = mid-career, 2 = senior clinicians. Equal
numbers of male and female clinicians.
Box 2
Example of a patient vignette; Patient 11
Patient 11 had refractory epilepsy for 27 years. Prior to TEC-referral
her epilepsy was misdiagnosed, and consequently, she was pre-
scribed numerousmedications,which did not control her symptoms
and was finally referred from her community neurologist to a spe-
cialist in hospital to assess her condition. She was initially hesitant
to seek this second opinion, saying: “I wasn't going to go to another
neurologist because I'd been to this fellow my whole time”. But
when she and her family were told about the epilepsy diagnosis
she felt such a relief she decided to pursue a hospital referral:
“And now everybody's suddenly putting all the pieces together”.
She was shocked when surgery was then offered: “When they
mentioned it I was crying going, ‘God no, you're not doing that to
me…’”. However, the neurosurgeon consultation reassured her,
as the surgeon noted: “We don't have anything to worry about be-
cause I do this every single day”. Her trust in him was reinforced
by another patient's recommendation, and through her own back-
ground reading: “I was getting that trust”. She now feels more opti-
mistic about surgery: “If they can fix it to an extent where it's not
going to bother me and it's going to make me a better quality of life
that'swhat Iwant.”She had beenworried about potential cognitive
deficits resulting from surgery but was more concerned about her
ongoing seizures: “As long as the turns don't happen anymore I
don't care” andher relief at the prospect of having her drugs reduced
was palpable: “I'm probably on about 12 tablets a day. If you can
knock me down to about three or four then I'll be happy with that”.
During the video-EEG assessment, she felt well-supported and
closely attended to, and while she was anxious about being taken
off medication and having seizures induced, she still felt positive:
“I was sitting there thinking ‘oh my God, it's going to happen’”.
Diagram 2. Level one: core factors in the individual patient model.
KEY: High-level domains in bold; internal characteristics in italics. 1. Patient-reported
experience of health and wellbeing: Personal, group, and societal knowledge of epilepsy;
views on health and wellbeing; sense of community belonging, social responsibility, and
social activity; self-care and self-management; expressed needs; and future goals. 2. Time
points: Individual care pathways, time lags, key time points, care as a continuum. 3.
Clinical factors: Expert knowledge, clinical information provision (within and outside
hospital), service access, and service use.
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shared understandings were noted across working groups.
As a result, Level One, The Individual Patient Model, came into
being. Level One emphasized the importance of patient knowledge
and understanding not only of the healthcare system, but also of the dis-
ease and ‘disease type’ (group-level or population-level experience), we
saw through our research, wantedmore detailed and nuanced informa-
tion about their disease and others' experiences of the disease, in order
to feel conﬁdent to progress with treatment and care. They also wanted
to understand the implications of the disease in the shorter and longer
term. Information helped patients manage their own care, and as a con-
sequence, led to less dependence on others such as family members.
When knowledge of the healthcare system, disease, and disease type
were forthcoming, patients' conﬁdence improved and so did their
mood. They felt more supported in pursing their health goals, such as
seizure reduction or eradication, evident through three high-level pa-
tient domains (external variables) and their associated internal charac-
teristics (Diagram 2).
2.2.2. Level two: the patient relationships model
Level Two is The Patient Relationships Model. Patient relation-
ships are deﬁned according to links with family, clinicians and others
in thewider healthcare system (Diagram 3). This is affected by patients'
emotional challenges, the personal strengths they ﬁnd to deal with
those, and an ongoing sense of community that is experienced when
services are provided by caring others. Level Two describes this in
terms of four essential, foregrounded component parts: 1) relationships
with family, 2) relationships with healthcare professionals and the
healthcare system, 3) inner strength and emotional challenges and
4) social connectedness. The internal characteristics are backgrounded
but provide the context to the relational qualities.
Level two derived from year-long observations, undertaken in the
TEC clinic settings, of clinicians, patients, and family members.Observations, an ethnographic, ‘in-context’, enculturated method [38],
enabled a study researcher, not directly involved in the events and
conversations being observed, to gather an independent perspective.
At different times and on different days observations were undertaken
Diagram 3. Relational qualities of PRIME and component parts in the exemplar case.
Source: Reconceptualized from Shih et al. [37].
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professionals, and decision-making around care pathways. This encour-
aged an in-depth assessment of patient consultations as patients
progressed toward surgical intervention. It included discussions of
blood tests, drug treatments and other therapies, surgery, and video
electroencephalography (EEG). The researcher considered the timing
of discussions, the language used by patients and healthcare profes-
sionals, and the intentions expressed. Field notes were taken of the in-
teractive process, emotive expression, environment and setting, and
themultifaceted nature of the “social worlds”withinwhich interactions
took place [38]. Observations were assessed alongside other data
(interview transcripts, ﬁeld notes, and medical records) using a
consensus-building, group work activity used extensively by the team
[34], while data triangulation led to an assessment of the relationship
between clinical interactions, care delivery, and system complexity.
Data revealed that positive clinical relationships help build trust in the
system, while optimism and hope reduce a patient's sense of isolation
and can alleviate social stigma. Nevertheless, patient and clinician
narratives and observations also indicated the extent to which
relationships were often in a state of ﬂux, as clinical and nonclinical
factors came into play to impact on patient positivity, trust and
optimism (Diagram 4).Diagram 4. Level two: core factors in the patient relationships model.2.2.3. Level three: the patient care pathways model
Level Three, The Patient Care PathwaysModel, exempliﬁes patient
journeys through care, which are always in ﬂux. This is implicit in the
way patients report their experience and their understanding of the
complex and rapidly adaptive world of healthcare delivery. Level
Three is the level where patients not only discuss the problems they
face as theymove through the system, but also the clinical activities un-
dertaken along the way.While The Patient Care Pathways Modelmight imply linearity, as
with other depictions of chronic conditions [33], this is not a linear pro-
gression.We have found that linearity does not adapt well to refractory
epilepsy, nor does it lend itself to patient narratives or to our observa-
tions of patients' progress through the system. Rather, activity centers
on the adjustments and accommodations made, and sometimes, the
dramatic twists and turns in patient journeys, which result in disjunc-
ture at different time points, such as delayed entry into hospital. Fig. 1
shows Patient 4's journey through care, with a qualifying statement in-
dicating how unexpected changes in patient experience turned a linear
journey into a fractured pathway. In Fig. 1, the patient's journey is de-
ﬁned by a number of seemingly arbitrary and changing pathways
Fig. 1. Patient 4's journey through care.
Source: Authors' own work.
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resulting in the patient moving around between systems and services,
with little to make sense of, or connect the different colored arrows to
each other.
While a fractured pathway is disadvantageous to practice and to
clinical teams, in terms of the energy and time needed to manage pa-
tients and move them through the healthcare system, we have discov-
ered that these fractures also have their advantages. Firstly, patients
have more time to look at new routes through care and to consider
whether surgical intervention, as one of a number of options that may
be available to them [39], including use of novel antiepileptic drugs, isthe most appropriate option. As they do so, they discuss clinical aspects
of care in more detail, such as drug testing, treatment, and assessment,
and alongwith their families, they begin to come to termswith new ap-
proaches at emotional, physical, and interactional levels. Secondly, pe-
riods of indecision compel patients and healthcare professionals to
come together to set a new course, and by so doing, to arrive at an ac-
commodation of one another. There is more time to think through op-
tions, ask questions, and discuss decisions with family members and
friends. Thirdly, real-time delays can ensure positive adjustments and
conformity to system adaptations. Disadvantageously, however, frac-
tured pathways lead to greater surgical lead-in time, greater resource
Diagram 6. Level four: core factors in the patient transitions model.Diagram 5. Level three: core factors in the patient care pathways model.
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bility that no surgery will take place at the end of a long period of con-
sideration. This can result from logistical complications, such as
patients living in remote and rural locations and being unable to access
the services they need when they need them, the challenges of deliver-
ing comprehensive care packages during a single patient visit, and com-
plications from patients' deteriorating health or a change of heart [40]
(Diagram 5).2.2.4. Level four: the patient transitions model
Level Four: The Patient Transitions Model indicates the way that
patients move between primary care, community neurology, and spe-
cialist neurology care in the TEC setting (Fig. 2). Level Fourwas derived
from a research project undertaken in a community setting (2017–
2018, ongoing), where a study researcher spent a year visiting commu-
nity neurologists at work in their clinic to collect in-depth, rich, and
context-driven data. The researcher interviewed patients and their fam-
ilies and community neurologists, examined interactions and
discussions with patients, and considered general practitioner (GP)
arrangements for care transitions and neurology referrals to TEC spe-
cialists. The researcher concentrated on the variety of patient pathways
to TEC referral and approaches to shared care, assessing how decisions
were made and what information was processed. In epilepsy research,
the subjective experience of patients often tends to be considered
using quantitative measures that fall short in revealing nuanced
experience and expression [41] while our qualitative work indicates
that patients project complex thoughts about treatment options that
quantitative tools simply cannot capture [30]. Level Four is the levelFig. 2. Patient pathways and clinical time points. Key: ____ Healthcare professional communicati
shared care that may take place.where the gaps that exist in knowledge become apparent, particularly
around: models of shared care delivery, approaches to shared
decision-making, and boundary-crossing. Level Four also identiﬁes
where weaknesses manifest in clinical feedback loops, and in the com-
munication between hospital specialists, GPs, community neurologists,
and patients.
Level Four is deﬁned according to six external variables: 1) team
work and team communication, 2) shared care, 3) individual care,
4) decision-making, 5) crossing boundaries, and 6) the clinical
feedback loop. These six variables accord with ﬁve internal
characteristics that relate to a patient's ability to ﬁnd the answers
to their questions and understand how to manage different healthcare
systems, ﬁnd satisfaction in services, and accommodate change
(Diagram 6).2.2.5. Level ﬁve: the pre- and postintervention model
Level Five: The Pre- and Postintervention Model concentrates
on intervention, and in the exemplar case, surgical intervention.
Level Five indicates the vital information that is currently missing
about the following: a) time lags between clinical stages of care,
b) knowledge of system intersections, complex systems, systemadapta-
tions, and system resilience. This has implications for strong clinical
leaders and patient resilience [42], in particular, in relation to the exter-
nal variables: diagnosis or misdiagnosis, drugs and drug-taking, tests,
and treatments and assessments, in association with the internal char-
acteristics: early epilepsy, GP, community neurology and neurosurgical
assessment, surgical and postsurgical rehabilitation, and follow-up and
ongoing adjustment (Diagram 7).on and shared care that does take place.———Healthcare professional communication and
Diagram 8. Level six: core factors in the comprehensive patient model.Diagram 7. Level ﬁve: core factors in the pre- and postintervention model.
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Level Six: TheComprehensive PatientModel is theﬁnal level of the
Model (Fig. 3 shows all six levels in combination, for the exemplar case).
Level Six is also the levelwhere all the other levels come together, in-
dicating their interconnected and relational qualities and how each
level leads to the next in terms of: 1) social networks and networking,
2) self-management and drug-taking, 3) information provision and
self-knowledge, 4) patient-reported outcomes, 5) clinical and nonclini-
cal factors, and 6) emotional and social aspects of health and wellbeing
including patient-reported QoL (Diagram 8).
Level Six also introduces, for the ﬁrst time, the notion of absent
voices. We have little information on the effect of, for example, the
clinician's opinion on patient decision-making, and we recognize
other absent yet inﬂuential voices, such as those of family and friends.
This is an underutilized resource [43,44], and yet PRIME is not unusual
in being incomplete in this way. Thus, while Level Six emphasizes theFig. 3. All six levels of tdetailed aspects of each level and overlaps, it also suggests macro and
micro-level omissions. While fewmodels present intrafamilial relation-
ships or patient–clinician dyads, Patient 9's vignette (Box 4) indicates
that gaining a more rounded understanding of seizure reduction and
patient adjustment, by introducing some of those absent voices, may
lend itself to richer and more rigorous reporting.
2.3. The utility of PRIME in clinical practice
An extensive evaluation of themodel's key internal and external var-
iables at each of the six critical levels is now planned, while a healthcare
professionalmodelwill help contextualize PRIME's practical and clinical
utility; PRIME has been developed to help illuminate how care is deliv-
ered in all its complexity, and to drive solutions to patient need and im-
prove clinical practice in refractory epilepsy. Internal and external
variables, across all six levels, will be tailored into a guide for practicehe patient model.
Box 4
Patient 9: patient–clinician dyad.
Twenty-seven years have elapsed since Patient 9 was first diag-
nosis with epilepsy. Since then he has undergone extensive as-
sessments, tests and treatments affecting his ability to maintain
a job. He has had two surgeries, which despite the personalized
nature of his care have taken their toll on him, leaving him emo-
tionally fragile, tearful, anddisillusioned. This has affected his con-
fidence levels, exacerbated by ongoing concerns about being able
to continue to support a disabled wife. Yet there are extensive
gaps in our understanding of presurgical experience, including
the period between first TEC visit and video-EEG assessment.
Did the views he held of excellent care create a sense of optimism
during the video-EEG assessment and surgery and can he with-
stand another surgery?To understand this better,we can consider
the views of supporting clinicians. While Clinicians 1 and 2 dis-
cuss improvements to patient mood and QoL postsurgery, Clini-
cians 2, 5, and 6 are much more circumspect, saying people like
Patient 9 often find it difficult to adapt, irrespective of surgical re-
sults, and often take at least a year to adjust to: “Not being the
centre of attention with their epilepsy. If you remove that from
them they can be psychologically stressed” (Clinician 5). Clinician
6 adds: “They're so much used to that disabled life, they can't get
used to their normal life, and that creates problems”.
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brings key stakeholders together to identify problems with care deliv-
ery, generate solutions, and reach decisions) [44]. The guidewill directly
link to the models' key components to address: improvements to path-
ways through care, treatment and other system delays, and barriers to
high-quality care. It will be created in such a way that proves easily ac-
cessible for busy clinicians, and it will take account of resource restric-
tions and gaps in treatments and services. Each of the guide's
component parts will be linked to key strategies and government policy
directivesmaking it both topical and evidence-based [15,45]. By provid-
ing identiﬁable features, healthcare professions will be able to engage
with the guide to direct their services and behaviors more appropri-
ately. In addition, the model will be modiﬁed for patient use, through
the development of information leaﬂets and service-orientation docu-
ments, delivered at different stages of care. The model will help to dis-
sect how services can support patients during: early epilepsy (public
as member of the community/professional as generalist), prediagnosis
to postdiagnosis (primary care); postdiagnosis to pre-TEC referral
(community neurology care); postsurgical follow-up to rehabilitation
(hospital care, specialist neurologist); and ongoing adjustment (pa-
tients returning to the community). Themodel will underpin the design
of an educational template, with the aim of enhancing patient-centered
care and patient-focused professional skills [46]. Thus, the versatility of
PRIME will help with the translation of research outputs into various
practical interventions aimed at improving care standards and care
quality. In particular, PRIME's utility will be to better rationalize factors
affecting patient progress through care and healthcare professional
decision-making, while more directed patient information will ensure
greater involvement in long-term disease management and self-care
[47–50].3. Discussion
In this paper, we have presented the PRIME model that will be of
beneﬁt to patients, healthcare researchers, and healthcare professionals
interested in chronic neurological conditions.Wehavemobilized PRIME
to understand the dimensions of a chronic disease through the exem-
plar case of refractory epilepsy, and have considered patients' healthand wellbeing, system gaps, barriers and facilitators to care and patient
need and expectation. The overarching model is patient rather than
clinician-driven, making it unique in this ﬁeld. It is deﬁned according
to six interlinking levels (Diagram 1 and Fig. 3), with the entry level
being ‘The Individual Patient’. The PRIME model embraces clinical and
nonclinical information and indicates that patients exist in a tense coex-
istence with others; PRIME offers the clearest picture to date of a
patient-drivenmodel for a chronic condition. It also points towhere fur-
ther information is nowneeded tomake it come alive as a usable service
guide, as patient information documentation, as an educational tool and
as an evidence-based intervention highlighting resource challenges and
system complexity. Key information about epilepsy clinicians' views
and experiences is now needed to ensure that the model is populated
and demonstrates utility in clinical practice and to ensure better care
transitions and reduced disease impact (individual, group, and societal).
The literature emphasizes that there is always an interplay between
physical and psychosocial domains in epilepsy [51,52], while theWorld
Health Organization (WHO) (2014) has recommended a thorough in-
vestigation of the way that social environments and social connections
shape not only physical but also mental health outcomes [53]. The posi-
tion of the WHO was preceded by the work of Jacoby and Baker [21].
Wilde et al. [54], for example, noted, through a suite of outcome mea-
sures, the importance of examining social role participation and patient
HRQOL, for proven utility in the care of brain injury. Yuill, Crinson, and
Duncan [55] identiﬁed six key aspects to this and presented a strong de-
fense of the examination of social support networks alongside personal
coping strategies. Yuill and colleagues [55] deﬁned these as critical if we
wish to understand social determinants of health and wellbeing, im-
prove population health, address mental health problems, and equalize
health discrepancies. The early work of Wilson and Cleary [56], on pa-
tient outcomes in medicine, paved the way for a conceptual model
that linked patientHRQOLmeasures to awide range of clinical variables.
They emphasized a clear relationship between different patient out-
comes and HRQOL, including general health perception, patient prefer-
ence, emotional response, and biological, physiological, and symptom
factors [56]. Wilson and Cleary noted that to optimize clinical interven-
tions attention should be given to causal pathways, and ourmodel offers
a route to achieving this, while bringing attention to both the disease
type and the individual. By doing so, PRIME has the capacity to identify
“major inﬂuences” that impact on patients' health and wellbeing, “and
the dynamic relationships among them” [57].
The PRIMEmodel is also the ﬁrstmodel to offer insights into the fea-
tures that will matter when we design and implement initiatives that
could improve tertiary, primary, and community healthcare services
for patients with refractory epilepsy. As a result, it has broad implica-
tions for other brain and neurological disorders and, beyond those, to
other chronic, complex conditions; PRIME illuminates how much of
what patients value stems from appropriate, clear, and speedy referrals,
from primary and community care settings to hospital specialists. This
could not only help build conﬁdence and trust in the healthcare system,
but also reinforces a patient's belief that the right, patient-focused clini-
cian can steer them toward more effective care, provided in the right
setting at the right time. As PRIME highlights, emotional challenges
often persist, despite tertiary care referrals, exacerbated by fracture
lines in the care system — a system that is forever changing — but this
could also lead to new approaches to conﬂict–resolution, and even ac-
ceptance of adaptations to care delivery.
3.1. Limitations
More extensive work on patient perspectives, through surveys or
focus groups, and a parallel healthcare professional model would com-
plement the work to date. The healthcare professional model would
also lead to consideration of barriers to implementation within the
healthcare setting, including resource limitations that affect the busy
life of the clinical practitioner, for example clinician time limitations,
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access to EEG monitoring beds and neuropsychology resources. More
information on these limitations and system restrictions would support
the value and use of PRIME, as patients enter and exit hospital, approach
surgical workup, and contend with follow-on care. We are aware, from
PRIME's content, that during a patient's journey, professionals make
complex, impactful decisions, while patients face radical life adjust-
ments, and the healthcare professional model would aim to account
for this, alongside system intersections at critical time points.
The PRIME model has indicated the importance of emotional resil-
ience in refractory epilepsy [7] as patients face personal challenges
and discover inner strengths. We must assess whether emotional
resilience is the primary motivating factor for surgical uptake, or one
of a number of factors. This will also indicate the capacity for emotional
resilience to be amarker ofmental health, social cohesion, and social ac-
tivity. We also need to take account of absent voices — the opinions of
clinicians, familymembers, and others— andhow intrafamilial relation-
ships inﬂuence patient decision-making.
In its ﬁrst iteration, we have created PRIME as a model that offers a
baseline from which to extend knowledge of the complex care systems
that surround chronic conditions'management. To give greater national
and international prominence to the use and value of PRIME, the work
might be expanded to other populations.
4. Conclusions
This work has offered a new evidence-base for framing the course of
a disease condition through the presentation of a comprehensivemodel
of patient-reported determinants of health and wellbeing. The PRIME
model can be adapted to other settings, patient populations, and condi-
tions. It provides a unique starting point to understand the experiential
knowledge of patients with refractory epilepsy of this debilitating con-
dition, and a complex assortment of clinical and nonclinical factors
intersecting across the care continuum. By evaluating themodel further
and extending it with professional-driven data, we can test it under a
range of conditions. That is the next task.
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